Ozempic & Obesity: WHO Support for Inequality – Today in EL PAÍS Podcast
- The World Health Association (WHO) has recognized weight-loss drugs as essential medicines.
- * The drugs can be a useful tool for some people with obesity.
- * The article is by Mario Fontán (social epidemiologist and advisor to the Ministry of Health) and Lucia Franco (EL PAÍS journalist who has investigated the black market...
Here’s a summary of the provided text:
The World Health Association (WHO) has recognized weight-loss drugs as essential medicines. This expands their previous classification, which limited their essential status to people with diabetes.
Key points from the WHO’s stance:
* The drugs can be a useful tool for some people with obesity.
* They are not a solution for everyone, nor should they be used as a standalone treatment without medical supervision.
* Access to these drugs should be worldwide and not limited to those who can afford them.
Additional Details:
* The article is by Mario Fontán (social epidemiologist and advisor to the Ministry of Health) and Lucia Franco (EL PAÍS journalist who has investigated the black market for these drugs).
* The text also provides credits for the podcast “Hoy en el país” (Sound design, directs, edition, tuning).
* Contact information is provided for complaints, doubts, or suggestions.
* The podcast is available on multiple platforms (podium Podcast,come on,Spotify,Apple Podcasts).